+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
Drug Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F- Product Image
New

Drug Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • PDF Icon

    Report

  • 185 Pages
  • November 2025
  • Region: Global
  • TechSci Research
  • ID: 5956438
Free Webex Call
10% Free customization
Description Jump to:

Injectable is the fastest growing segment, North America is the largest regional market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Drug Delivery Devices Market, valued at USD 261.32 Billion in 2024, is projected to experience a CAGR of 7.91% to reach USD 412.66 Billion by 2030. Drug delivery devices are specialized medical technologies engineered to administer therapeutic substances to the body in a controlled and optimized manner, encompassing various routes such as injectable, oral, transdermal, and inhalation systems. The market's expansion is significantly driven by the increasing global prevalence of chronic diseases requiring long-term medication management and a growing demand for patient-centric care solutions, including self-administration.

Key Market Drivers

The increasing global burden of chronic diseases significantly propels the demand for drug delivery devices, as effective long-term management of conditions like diabetes, cardiovascular diseases, and cancer necessitates reliable and often specialized administration methods. This demographic shift towards an older population with higher rates of comorbidities fuels the need for advanced solutions capable of precise dosing and improved patient adherence across various care settings, including home care. According to the World Health Organization's "Noncommunicable diseases" fact sheet, in 2021, 43 million people died from an NCD, accounting for 75% of non-pandemic-related deaths globally, underscoring the widespread need for effective therapeutic interventions delivered efficiently via modern devices.

Key Market Challenges

The complex and evolving regulatory landscape across different regions presents a significant impediment to the growth of the Global Drug Delivery Devices Market. Varying requirements for product development, clinical trials, and post-market surveillance introduce substantial unpredictability and complexity for manufacturers. This intricacy often leads to extended approval timelines and increased development expenditures, particularly for innovative combination products that integrate drugs and devices.

Key Market Trends

The rapid expansion of home-based and self-administration devices marks a transformative shift in healthcare delivery, enabling patients to manage treatments independently beyond conventional clinical settings. This evolution is primarily driven by growing demand for convenience, cost efficiency, and improved treatment adherence, particularly in chronic disease management.

These solutions include user-friendly technologies such as pre-filled syringes, auto-injectors, and patch pumps, which simplify drug administration and improve the overall patient experience. Reflecting this structural change, MedTech Europe projects that the home-care segment will grow at a compound annual growth rate of 12.4% within the European medical devices market from 2025 to 2033, highlighting the accelerating transition toward decentralised care models. This momentum is further reinforced by strategic investments from leading manufacturers; for instance, Medtronic expanded 11 production lines for insulin pumps in Ireland in 2023, demonstrating its commitment to scaling capacity in response to rising demand for self-administered diabetes management solutions.

Key Market Players Profiled:

  • Pfizer Inc.
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Johnson and Johnson
  • Bayer AG
  • Becton, Dickinson and Company
  • Altaris Capital Partners, LLC
  • Holozymes Inc. (Antares Pharma Inc.)
  • GlaxoSmithKline PLC
  • Teva Pharmaceutical Industries Ltd

Report Scope:

In this report, the Global Drug Delivery Devices Market has been segmented into the following categories:

By Application:

  • Cancer
  • Cardiovascular
  • Diabetes
  • Infectious Diseases
  • Other Applications

By Route of Administration:

  • Injectable
  • Topical
  • Ocular
  • Others

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Drug Delivery Devices Market .

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Drug Delivery Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Application (Cancer, Cardiovascular, Diabetes, Infectious Diseases, Other Applications)
5.2.2. By Route of Administration (Injectable, Topical, Ocular, Others)
5.2.3. By End User (Hospitals, Ambulatory Surgical Centers, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Drug Delivery Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Application
6.2.2. By Route of Administration
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Drug Delivery Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Application
6.3.1.2.2. By Route of Administration
6.3.1.2.3. By End User
6.3.2. Canada Drug Delivery Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Application
6.3.2.2.2. By Route of Administration
6.3.2.2.3. By End User
6.3.3. Mexico Drug Delivery Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Application
6.3.3.2.2. By Route of Administration
6.3.3.2.3. By End User
7. Europe Drug Delivery Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Application
7.2.2. By Route of Administration
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Drug Delivery Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Application
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By End User
7.3.2. France Drug Delivery Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Application
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By End User
7.3.3. United Kingdom Drug Delivery Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Application
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By End User
7.3.4. Italy Drug Delivery Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Application
7.3.4.2.2. By Route of Administration
7.3.4.2.3. By End User
7.3.5. Spain Drug Delivery Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Application
7.3.5.2.2. By Route of Administration
7.3.5.2.3. By End User
8. Asia-Pacific Drug Delivery Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Application
8.2.2. By Route of Administration
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Drug Delivery Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Application
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By End User
8.3.2. India Drug Delivery Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Application
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By End User
8.3.3. Japan Drug Delivery Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Application
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By End User
8.3.4. South Korea Drug Delivery Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Application
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By End User
8.3.5. Australia Drug Delivery Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Application
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By End User
9. Middle East & Africa Drug Delivery Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Application
9.2.2. By Route of Administration
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Drug Delivery Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Application
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By End User
9.3.2. UAE Drug Delivery Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Application
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By End User
9.3.3. South Africa Drug Delivery Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Application
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By End User
10. South America Drug Delivery Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Application
10.2.2. By Route of Administration
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Drug Delivery Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Application
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By End User
10.3.2. Colombia Drug Delivery Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Application
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By End User
10.3.3. Argentina Drug Delivery Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Application
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Drug Delivery Devices Market : SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Pfizer Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Novartis AG
15.3. F. Hoffmann-La Roche Ltd
15.4. Johnson and Johnson
15.5. Bayer AG
15.6. Becton, Dickinson and Company
15.7. Altaris Capital Partners, LLC
15.8. Holozymes Inc. (Antares Pharma Inc.)
15.9. GlaxoSmithKline PLC
15.10. Teva Pharmaceutical Industries Ltd
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

The companies profiled in this Drug Delivery Devices market report include:
  • Pfizer Inc.
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Johnson and Johnson
  • Bayer AG
  • Becton, Dickinson and Company
  • Altaris Capital Partners, LLC
  • Holozymes Inc. (Antares Pharma Inc.)
  • GlaxoSmithKline PLC
  • Teva Pharmaceutical Industries Ltd

Table Information

Report AttributeDetails
No. of Pages185
PublishedNovember 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 261.32 Billion
Forecasted Market Value ( USD ) by 2030 $ 412.66 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Connected Drug Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Connected Drug Delivery Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Drug Delivery Devices Market Report 2025 - Product Image

Drug Delivery Devices Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Subcutaneous Biologics Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Biologic, Type of Therapy, End User, Payment Method Employed, Therapeutic Area, Drug Delivery Device, Geographical Regions, Leading Players and Sales Forecast of Drugs - Product Image

Subcutaneous Biologics Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Biologic, Type of Therapy, End User, Payment Method Employed, Therapeutic Area, Drug Delivery Device, Geographical Regions, Leading Players and Sales Forecast of Drugs

  • Report
  • 997 Pages
  • Global
From
Connected Drug Delivery Devices Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Mode of Connectivity, Route of Administration, Therapeutic Area and Geographical Region - Product Image

Connected Drug Delivery Devices Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Device, Mode of Connectivity, Route of Administration, Therapeutic Area and Geographical Region

  • Report
  • 405 Pages
  • Global
From
Connected Drug Delivery Devices - Global Strategic Business Report - Product Image

Connected Drug Delivery Devices - Global Strategic Business Report

  • Report
  • 172 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.